Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer at Merck, where she is responsible for patient engagement, communications, policy, philanthropic and other functions. She joined Merck in 2010 as president of Merck Vaccines. Dr. Gerberding previously served as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009.